Libni Eapen

Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial

Anthony C. Nichols, Julie Theurer, Eitan Prisman et al. · The Lancet Oncology · 2019 · 462 citations

Medicine, Oncology, Surgery +10

Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement

Matthew I. Milowsky, R. Bryan Rumble, Christopher M. Booth et al. · Journal of Clinical Oncology · 2016 · 236 citations

Medicine, Oncology, Urology +16

Early-stage squamous cell carcinoma of the oropharynx: Radiotherapy vs. Trans-Oral Robotic Surgery (ORATOR) – study protocol for a randomized phase II trial

Anthony C. Nichols, John Yoo, J. Alex Hammond et al. · BMC Cancer · 2013 · 141 citations · Full text

Medicine, Oncology, Surgery +17

A prospective clinical trial of green tea for hormone refractory prostate cancer: An evaluation of the complementary/alternative therapy approach

E Choan, Roanne Segal, Derek J. Jonker et al. · Urologic Oncology Seminars and Original Investigations · 2005 · 136 citations

Medicine, Oncology, Urology +7

Final Report of Multicenter Canadian Phase III Randomized Trial of 3 Versus 8 Months of Neoadjuvant Androgen Deprivation Therapy Before Conventional-Dose Radiotherapy for Clinically Localized Prostate Cancer

Juanita Crook, Charles Ludgate, Shawn Malone et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 116 citations

Medicine, Oncology, Urology +14